Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial
This study confirmed the safety and feasibility of subcallosal cingulate DBS as a treatment for treatment-resistant depression but did not show statistically significant antidepressant efficacy in a 6-month double-blind, sham-controlled trial. Future studies are needed to investigate factors such as clinical features or electrode placement that might improve efficacy. Funding Abbott (previously St Jude Medical).
Source: The Lancet Psychiatry - Category: Psychiatry Source Type: research
More News: Brain | Computers | Deep Brain Stimulation | Depression | Honey | Neurology | Psychiatry | Statistics | Study